CHB Investment Group LLC Sells 181 Shares of The Allstate Co. (NYSE:ALL)

CHB Investment Group LLC trimmed its position in shares of The Allstate Co. (NYSE:ALLFree Report) by 1.1% during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 15,816 shares of the insurance provider’s stock after selling 181 shares during the quarter. Allstate accounts for approximately 1.7% of CHB Investment Group LLC’s holdings, making the stock its 13th largest position. CHB Investment Group LLC’s holdings in Allstate were worth $3,049,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds have also recently modified their holdings of the company. Pathway Financial Advisers LLC boosted its stake in shares of Allstate by 18,472.5% during the 3rd quarter. Pathway Financial Advisers LLC now owns 1,052,687 shares of the insurance provider’s stock worth $199,642,000 after acquiring an additional 1,047,019 shares during the last quarter. Allspring Global Investments Holdings LLC lifted its position in shares of Allstate by 18.7% during the 3rd quarter. Allspring Global Investments Holdings LLC now owns 3,000,866 shares of the insurance provider’s stock valued at $569,114,000 after buying an additional 472,040 shares in the last quarter. AQR Capital Management LLC grew its stake in shares of Allstate by 181.6% during the 2nd quarter. AQR Capital Management LLC now owns 719,997 shares of the insurance provider’s stock valued at $114,955,000 after acquiring an additional 464,337 shares during the period. TimesSquare Capital Management LLC purchased a new stake in Allstate in the 3rd quarter worth approximately $77,819,000. Finally, Los Angeles Capital Management LLC raised its stake in Allstate by 688.4% during the 3rd quarter. Los Angeles Capital Management LLC now owns 460,282 shares of the insurance provider’s stock worth $87,292,000 after acquiring an additional 401,901 shares during the period. 76.47% of the stock is currently owned by hedge funds and other institutional investors.

Allstate Trading Up 0.9 %

ALL opened at $182.63 on Tuesday. The Allstate Co. has a 12 month low of $150.17 and a 12 month high of $209.88. The stock has a fifty day moving average price of $195.85 and a 200-day moving average price of $185.88. The firm has a market cap of $48.36 billion, a price-to-earnings ratio of 11.83, a PEG ratio of 1.70 and a beta of 0.52. The company has a current ratio of 0.40, a quick ratio of 0.40 and a debt-to-equity ratio of 0.43.

Allstate (NYSE:ALLGet Free Report) last released its quarterly earnings results on Wednesday, October 30th. The insurance provider reported $3.91 earnings per share for the quarter, beating analysts’ consensus estimates of $2.20 by $1.71. The business had revenue of $16.63 billion for the quarter, compared to analysts’ expectations of $14.57 billion. Allstate had a net margin of 6.77% and a return on equity of 26.67%. The company’s revenue was up 14.7% compared to the same quarter last year. During the same period last year, the business earned $0.81 EPS. As a group, equities research analysts anticipate that The Allstate Co. will post 16.26 earnings per share for the current fiscal year.

Allstate Dividend Announcement

The firm also recently declared a quarterly dividend, which was paid on Thursday, January 2nd. Stockholders of record on Friday, November 29th were given a dividend of $0.92 per share. This represents a $3.68 dividend on an annualized basis and a dividend yield of 2.02%. The ex-dividend date was Friday, November 29th. Allstate’s payout ratio is presently 23.83%.

Analyst Ratings Changes

A number of research firms have commented on ALL. UBS Group raised their price target on Allstate from $216.00 to $225.00 and gave the company a “buy” rating in a report on Monday, November 4th. Evercore ISI raised Allstate from an “in-line” rating to an “outperform” rating in a research note on Wednesday, January 8th. Jefferies Financial Group raised their target price on shares of Allstate from $231.00 to $267.00 and gave the stock a “buy” rating in a report on Friday, November 8th. Keefe, Bruyette & Woods boosted their target price on Allstate from $235.00 to $243.00 and gave the company an “outperform” rating in a research report on Friday. Finally, Wells Fargo & Company increased their price target on Allstate from $175.00 to $186.00 and gave the stock an “equal weight” rating in a report on Tuesday, November 5th. One research analyst has rated the stock with a sell rating, one has issued a hold rating, fourteen have assigned a buy rating and one has issued a strong buy rating to the company. According to data from MarketBeat, the company has a consensus rating of “Moderate Buy” and a consensus target price of $218.06.

Get Our Latest Analysis on ALL

Allstate Profile

(Free Report)

The Allstate Corporation, together with its subsidiaries, provides property and casualty, and other insurance products in the United States and Canada. It operates in five segments: Allstate Protection; Protection Services; Allstate Health and Benefits; Run-off Property-Liability; and Corporate and Other segments.

See Also

Institutional Ownership by Quarter for Allstate (NYSE:ALL)

Receive News & Ratings for Allstate Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Allstate and related companies with MarketBeat.com's FREE daily email newsletter.